| Hang Seng Index | 27.200 HKD | +0.020 | +0.074% | 838.71M | 22.79B | 27.196 (+0.017%) HKD as at 2025/09/18 | | |
| Hang Seng TECH Index | 6.175 HKD | +0.020 | +0.325% | 3.04B | 18.82B | 6.156 (+0.305%) HKD as at 2025/09/18 | | |
| Hang Seng China Enterprises | 97.200 HKD | +0.620 | +0.642% | 143.63M | 13.89B | 96.626 (+0.595%) HKD as at 2025/09/18 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 6.995 HKD | +0.050 | +0.720% | 217.23M | 1.52B | 6.958 (+0.532%) HKD as at 2025/09/18 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.174 HKD | -0.010 | -0.845% | 696.64M | 818.19M | 1.184 (-0.861%) HKD as at 2025/09/18 | | |
| Hang Seng TECH Index | 13.220 HKD | +0.010 | +0.076% | 21.66M | 287.36M | 13.219 (+0.009%) HKD as at 2025/09/18 | | |
| Hang Seng TECH Index | 6.270 HKD | +0.020 | +0.320% | 42.58M | 267.29M | 6.252 (+0.281%) HKD as at 2025/09/18 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.762 HKD | 0.000 | 0.000% | 147.85M | 260.90M | 1.761 (+0.040%) HKD as at 2025/09/18 | | |
| FTSE China A50 | 16.040 HKD | +0.020 | +0.125% | 11.20M | 179.51M | 16.013 (+0.170%) HKD as at 2025/09/18 | | |
| Hang Seng China Enterprises | 10.830 HKD | +0.020 | +0.185% | 15.24M | 164.85M | 10.810 (+0.182%) HKD as at 2025/09/18 | | |
| CSI 300 | 51.020 HKD | +0.040 | +0.078% | 2.48M | 126.46M | 50.917 (+0.203%) HKD as at 2025/09/18 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 6.415 HKD | -0.005 | -0.078% | 19.13M | 122.68M | 6.421 (-0.097%) HKD as at 2025/09/18 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 17.300 HKD | -0.200 | -1.143% | 3.36M | 58.33M | 17.652 (-1.993%) HKD as at 2025/09/18 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 19.690 HKD | -0.060 | -0.304% | 2.13M | 41.86M | 19.593 (+0.497%) HKD as at 2025/09/18 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 7.515 HKD | -0.055 | -0.727% | 4.87M | 36.80M | 7.589 (-0.974%) HKD as at 2025/09/18 | | |
| London Gold Fixing Price | 2,618.000 HKD | -2.000 | -0.076% | 13.29K | 34.72M | 338.850 (-0.616%) USD as at 2025/09/17 | | |
| FTSE US Treasury 20+ Years Index | 69.360 HKD | -1.140 | -1.617% | 437.71K | 30.42M | 69.560 (-0.288%) HKD as at 2025/09/18 | | |
| FTSE China A50 | 14.920 HKD | +0.030 | +0.201% | 1.87M | 27.94M | 14.922 (-0.010%) HKD as at 2025/09/18 | | |
| Hang Seng High Dividend Yield | 30.780 HKD | +0.180 | +0.588% | 682.72K | 20.96M | 30.568 (+0.693%) HKD as at 2025/09/18 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.474 HKD | -0.006 | -0.172% | 5.75M | 19.93M | 3.467 (+0.193%) HKD as at 2025/09/18 | | |
| FactSet China Semiconductor Index (net total return) | 57.000 HKD | -1.880 | -3.193% | 322.33K | 18.53M | 57.398 (-0.694%) HKD as at 2025/09/18 | | |
| Hang Seng Index (net total return version) | 97.860 HKD | -0.080 | -0.082% | 187.71K | 18.36M | 97.876 (-0.017%) HKD as at 2025/09/18 | | |
| MSCI China | 28.520 HKD | -0.020 | -0.070% | 612.04K | 17.45M | 28.515 (+0.019%) HKD as at 2025/09/18 | | |
| SSE Science and Technology Innovation Board 50 Index | 12.570 HKD | -0.070 | -0.554% | 1.18M | 14.91M | 12.732 (-1.269%) HKD as at 2025/09/18 | | |
| CSI 300 | 33.540 HKD | +0.160 | +0.479% | 333.96K | 11.18M | 33.350 (+0.569%) HKD as at 2025/09/18 | | |
| CSI 300 | 46.700 CNY | +0.100 | +0.215% | 238.21K | 11.12M | 46.562 (+0.297%) CNY as at 2025/09/18 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 10.790 HKD | -0.090 | -0.827% | 954.16K | 10.33M | 10.864 (-0.677%) HKD as at 2025/09/18 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 4.724 HKD | +0.052 | +1.113% | 2.04M | 9.59M | 4.708 (+0.342%) HKD as at 2025/09/18 | | |
| Solactive China Healthcare Disruption Index | 4.122 HKD | -0.076 | -1.810% | 2.29M | 9.52M | 4.197 (-1.780%) HKD as at 2025/09/18 | | |
| FactSet China Robotics and Artificial Intelligence Index (net total return) | 64.540 HKD | +0.380 | +0.592% | 127.81K | 8.13M | 63.689 (+1.336%) HKD as at 2025/09/18 | | |